1. Anti-Drug Falsification Work Group GT/CFM 6th Conference of the PARF Network Brasilia, 07 July 2011

2. Members of the GT/CFM
MERCOSUR: Tiago Lanius Rauber, Brazil (Coordinator).
ANDEAN COMMUNITY: Marisa Papen, Peru.
SICA: Eric Conte, Panama.
NAFTA: Michelle Limoli, USA
ALIFAR: Miguel A. Maito, Argentina.
CARICOM: Princess Osbourne, Jamaica
FIFARMA: Néstor Garrido Aranda, Peru. 
Appointed by the OPS: María José Sánchez, Argentina.    
Secretary (OPS/OMS): José Luis Castro, Washington, DC.
Alternate Members
MERCOSUR: María José Sánchez, Argentina.
COMUNIDAD ANDINA: Delia Villaroel, Bolivia.
SICA: Reynaldo Hevia Pumariega, Cuba.
CARICOM: David Crawford.
ALIFAR: Carmen E. Perez.
Colaboradores
Leandro Teixeira de Morais, Brasil.
Maristela de Almeida, Brasil.
Maximiliano Derecho, Argentina.

3. Background 1999 2nd PARF Conference Creation of the GT/CFM 2001
1st GT meeting
Prepared the diagnostic survey
2002
3rd PARF Conference
Presented the diagnostic and approved the work plan
2003
2nd GT meeting
Developed the mission and objectives of the GT
2004
3rd GT meeting
Proposed training for health authorities
2005
4th PARF Conference
Approval of documents: Critical Path; Executive Unit; Indicators and Education Program
2006
4th GT meeting
Update of the Education Program
2008
Discussion Meeting on Tools and Generation of Proposals for the Prevention and Combating of Falsified Drugs – holding of pilot in Panama
5th PARF Conference
Approval of documents: Network Focal Points and Discussion Meetings and work plan

4. Activities Performed
Holding the Meetings in Bolivia (2009), Jamaica / CARICON and English Caribbean (2009) and Costa Rica (2011)
Update of the introduction and reference document for the Tools Discussion Meetings and Generation of Proposals to Prevent and Combat the Falsification of Drugs (2010 – 2011)
Update of the reference document on the Focal Points for the Prevention and Combating of the Falsification of Drugs and Medical Products (2010 – 2011)
Preparation of the outline of the Guidelines to be Considered by the Health Authorities Faced with Suspicion of Falsification of Drugs and Medical Products (2011)

5. Documents Presented for Approval
1. Update of the reference document for the Tools Discussion and Generation of Proposals Meeting
Improvements identified based on the experiences in Panama, Bolivia and Jamaica
Establish a strategy to strengthen the health authorities confronting the problem
Structure an inter-institutional committee to face the problem nationally
Establish mechanisms for preparing the meeting so as to expand the working liaisons between the GT/CFM and the health authority in the country
Review the planned program
Establish a methodology to monitor and follow up
Preparation of the Introduction and Awareness Document

6. Panama Progress from the Meetings held in 2008
Cooperation Agreement between the Ministry of Health, the Public Ministry, the General Customs Authority, National Police and University of Panama, to form an inter-institutional executive committee to prevent and detect falsified pharmaceutical products – 05 March 2009
Among the objectives of the agreement are: To prepare, develop, present, and update an interoperability protocol and procedures manuals.
Performing 10 joint operations by the Public Ministry, the Ministry of Health and the National Police, with cooperation from the industry
Investigation of administrative and criminal cases

7. Panama Progress from the Meetings held in 2008
Other products of the Cooperation Agreement
14 meetings of the inter-institutional committee
8 meetings of the support committee
6 national seminars
More than 700 people trained
Dissemination to the media or the public
Committee forecasts
Forming of the National Border Service, Naval Air Service, Judiciary and Legislative Assembly
National dissemination campaign
International cooperation
Create an inquiry and information website

8. Documents Presented for Approval
2. Updating the Reference Document on the Network Focal Points for the Prevention and Combating of Drug and Medical Product Falsification
Objective To strengthen communication and effective cooperation between the Party States through the health authorities, in order to protect the population against the falsification of drugs and medical products.
Subjects proposed for discussion
Structure and functioning of the Network
Responsibilities of the National and Subregional Focal Point
Implementation and maintenance of the PFCF Network
Public Hearing from April 19 to June 10, 2011

9. Documents Presented for Approval
Proposed Structure – PFCF Network
GT/CFM/OPS
PFCF
CAN
CARICOM
SICA
Mercosur
NAFTA
NATIONAL
PFCF’s

10. Documents Presented for Approval
3. Guidelines to be Considered by the Health Authorities Faced with a Suspicion of Falsified Drugs and Medical Products
The purpose of this document is to provide common action guidelines, based on the experiences seen in the countries in the region, to be considered by the health authorities for the effects of defining and taking action in view of a suspicion of falsified medical products in the market.
Public hearing from May 11 through June 12, 2011

11. Documents Presented for Approval
Guidelines to be Considered by the Health Authorities Faced with a Suspicion of Falsified Drugs and Medical Products
Objectives of the actions of the health authority faced with suspicions
Confirm and define the falsification;
Limit and interrupt the harmful effects of the falsification;
Communicate and disseminate the case;
Identify the perpetrators of the fabrication and distribution of the falsified product.
Planning and Conducting of Inspections

12. Work Plan 2011 - 2014 ACTIVITY DATE February/2012
1. Effectively implement the Focal Point Network according to the document to be approved in the 6th Conference.
February/2012
2. Promote Discussion and Proposal Generation Meetings in the countries in the region (maximum 2 events per year).
Ongoing Activity
3. Follow-up and support of the countries where the Meetings were held.
4. Participate on the task force for preparing the distribution good practices guidelines, [if?] approved by the Conference.
March/2013
5. Review the critical path and operating unit documents.
October/2013
6. Prepare a guideline on the legislative aspects related to combating the falsification of drugs and medical products.
November/2013
7. Evaluate and analyze the technologies and experiences existing in the region for the traceability of drugs and medical products
March / 2012

13. Work Plan 2011 - 2014 ACTIVITY DATE November/2013
8. Evaluate and analyze the existing technologies and experiences in the region to control the improper sale of drugs and medical products over the Internet.
November/2013